Testing algorithms for determination of recent (R) and long-term (LT) HIV-1 infections by the (a) LAg and (b) BRAI avidity assays. Dashed arrows in the algorithms indicate that all specimens classified as LAg-pending were reclassified as R because all samples were collected from persons confirmed to be HIV-positive and all BRAI-invalid results were reclassified as R because all samples were collected from individuals who were confirmed to have HIV infection, were treatment naïve and not classified as having AIDS. *BRAI cut-off is the mean of the optical density of the assay negative controls plus 0.250. ODn, normalized optical density.</p
<p>Probability curves were generated by analyzing samples from three cohort studies (see <a href="ht...
The variety and limitations of current laboratory methods for estimating HIV-incidence has driven at...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidence h...
BackgroundSerological assays to determine HIV incidence have contributed to estimates of HIV inciden...
BACKGROUND: Serological assays to determine HIV incidence have contributed to estimates of HIV incid...
<div><p>Background</p><p>Accurate and practical biologic tools to estimate HIV incidence is crucial ...
Determination of recent (R) and long-term (LT) HIV-1 infections by LAg and BRAI without inclusion of...
Background Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infec-t...
<p>The figure shows the multi-assay algorithm that was applied for the 2012 HIV incidence estimation...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for c...
Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify th...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
<p>Probability curves were generated by analyzing samples from three cohort studies (see <a href="ht...
The variety and limitations of current laboratory methods for estimating HIV-incidence has driven at...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidence h...
BackgroundSerological assays to determine HIV incidence have contributed to estimates of HIV inciden...
BACKGROUND: Serological assays to determine HIV incidence have contributed to estimates of HIV incid...
<div><p>Background</p><p>Accurate and practical biologic tools to estimate HIV incidence is crucial ...
Determination of recent (R) and long-term (LT) HIV-1 infections by LAg and BRAI without inclusion of...
Background Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infec-t...
<p>The figure shows the multi-assay algorithm that was applied for the 2012 HIV incidence estimation...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for c...
Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify th...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
<p>Probability curves were generated by analyzing samples from three cohort studies (see <a href="ht...
The variety and limitations of current laboratory methods for estimating HIV-incidence has driven at...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidence h...